Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-29 @ 7:35 AM
Study NCT ID:
NCT01086657
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2010-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-25
Start Date Type:
None
Primary Completion Date:
2011-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-12
First Submit QC Date:
None
Study First Post Date:
2010-03-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL